Orient EuroPharma Co., Ltd. (TPEX: 4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.40
-0.75 (-1.53%)
Nov 18, 2024, 1:30 PM CST
23.31%
Market Cap 4.18B
Revenue (ttm) 4.47B
Net Income (ttm) 190.91M
Shares Out 86.75M
EPS (ttm) 2.20
PE Ratio 21.86
Forward PE n/a
Dividend 1.00 (2.08%)
Ex-Dividend Date Jul 19, 2024
Volume 33,685
Open 49.00
Previous Close 49.15
Day's Range 48.30 - 49.00
52-Week Range 36.70 - 55.90
Beta 0.41
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.